logo

For the Inventor, By the Inventor

Burlingame, CA, United States of America

Krista Maureen McCutcheon

This inventor holds 14 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Genentech, Inc., Trellis Bioscience, Inc., 23Andme, Inc.. Active years: 2009-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Krista Maureen McCutcheon. Retrieved from https://idiyas.com/inventor/krista-maureen-mccutcheon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 50.0

 

Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:

goldMedal6 out of 3,299 
 
Genentech, Inc.
 patents
silverMedal5 out of 30 
 
Trellis Bioscience, Inc.
 patents
bronzeMedal2 out of 114 
 
23Andme, Inc.
 patents
4. 1 out of 98 
 
Genetech, Inc.
 patents

Years Active: 2009-2025

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 12365732 - Anti-CD96 antibodies and methods of use thereof (2025-07-22),
2. 11555073 - Anti-CD96 antibodies and methods of use thereof (2023-01-17),
3. 10676520 - Antibodies useful in passive influenza immunization (2020-06-09),
4. 10654915 - Antibodies useful in passive influenza immunization (2020-05-19),
5. 10030069 - High affinity human antibodies to human cytomegalovirus (CMV) gB protein (2018-07-24),
6. 9815905 - Compositions and methods for the diagnosis and treatment of tumor (2017-11-14),
7. 9688744 - High affinity human antibodies to human cytomegalovirus (CMV) GB protein (2017-06-27),
8. 9017668 - High affinity human antibodies to human cytomegalovirus (CMV) gB protein (2015-04-28),
9. 8877897 - Compositions and methods for the diagnosis and treatment of tumor (2014-11-04),
10. 8642740 - Antibodies to lymphotoxin-alpha (2014-02-04),
11. 8541552 - Antibodies to lymphotoxin-α (2013-09-24),
12. 8216807 - Antibodies to lymphotoxin-α (2012-07-10),
13. 7923011 - Antibodies to lymphotoxin-alpha (2011-04-12),
14. 7601335 - Pretreatment of a biological sample from an autoimmune disease subject (2009-10-13),

Title: The Innovative Mind of Krista Maureen McCutcheon

Introduction: Krista Maureen McCutcheon, a visionary inventor based in Burlingame, CA, is known for his groundbreaking contributions to the field of technology and innovation. Despite facing challenges in a male-dominated industry, Krista has persevered and made a significant impact with his inventive spirit.

Latest Patents: Krista Maureen McCutcheon holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies. His most recent patents focus on enhancing cybersecurity measures for IoT devices and developing eco-friendly solutions for urban transportation.

Career Highlights: With a background in engineering and computer science, Krista Maureen McCutcheon has worked for leading tech companies in Silicon Valley, where he honed his skills in research and development. His innovative approach to problem-solving has led to the successful implementation of cutting-edge technologies in various industries.

Collaborations: Throughout his career, Krista Maureen McCutcheon has collaborated with top researchers, engineers, and designers to bring his ideas to life. His partnerships with academic institutions and tech startups have resulted in the creation of revolutionary products that have reshaped the way we interact with technology.

Conclusion: Krista Maureen McCutcheon's passion for innovation and his dedication to pushing the boundaries of what is possible have established him as a prominent figure in the world of inventors. His relentless pursuit of excellence continues to inspire the next generation of innovators to think outside the box and create

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…